Marshall Wace North America L.P. Sells 5,945 Shares of Houlihan Lokey Inc (NYSE:HLI)

Marshall Wace North America L.P. cut its stake in shares of Houlihan Lokey Inc (NYSE:HLI) by 38.9% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,342 shares of the financial services provider’s stock after selling 5,945 shares during the period. Marshall Wace North America L.P.’s holdings in Houlihan Lokey were worth $428,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC raised its holdings in Houlihan Lokey by 3.8% during the fourth quarter. Janney Montgomery Scott LLC now owns 7,364 shares of the financial services provider’s stock valued at $271,000 after acquiring an additional 270 shares during the period. Hsbc Holdings PLC increased its holdings in shares of Houlihan Lokey by 13.6% in the fourth quarter. Hsbc Holdings PLC now owns 6,055 shares of the financial services provider’s stock worth $222,000 after purchasing an additional 725 shares during the last quarter. Legal & General Group Plc increased its holdings in shares of Houlihan Lokey by 15.2% in the fourth quarter. Legal & General Group Plc now owns 6,115 shares of the financial services provider’s stock worth $225,000 after purchasing an additional 807 shares during the last quarter. Citigroup Inc. increased its holdings in shares of Houlihan Lokey by 5.3% in the fourth quarter. Citigroup Inc. now owns 19,475 shares of the financial services provider’s stock worth $717,000 after purchasing an additional 974 shares during the last quarter. Finally, US Bancorp DE increased its holdings in shares of Houlihan Lokey by 6.8% in the first quarter. US Bancorp DE now owns 16,072 shares of the financial services provider’s stock worth $736,000 after purchasing an additional 1,024 shares during the last quarter. Institutional investors own 58.05% of the company’s stock.

In other Houlihan Lokey news, major shareholder Orix Hlhz Holding Llc sold 3,000,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $45.52, for a total transaction of $136,560,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 80.50% of the company’s stock.

HLI has been the topic of several research reports. ValuEngine cut Intersect ENT from a “buy” rating to a “hold” rating in a report on Monday, July 8th. Goldman Sachs Group reaffirmed a “sell” rating and issued a $45.00 target price on shares of Intel in a report on Wednesday, April 3rd. JMP Securities reduced their target price on BioCryst Pharmaceuticals from $18.00 to $10.00 and set an “outperform” rating on the stock in a report on Thursday, May 23rd. Buckingham Research reduced their target price on PJT Partners from $49.00 to $42.00 and set a “neutral” rating on the stock in a report on Thursday, July 11th. Finally, Zacks Investment Research cut ExlService from a “hold” rating to a “sell” rating in a report on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $50.08.

NYSE HLI traded up $0.07 during trading hours on Thursday, hitting $43.75. 165,359 shares of the company were exchanged, compared to its average volume of 246,030. The stock has a 50-day moving average price of $44.93. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.01. Houlihan Lokey Inc has a 52 week low of $34.31 and a 52 week high of $53.20. The stock has a market capitalization of $2.89 billion, a PE ratio of 15.24, a PEG ratio of 1.16 and a beta of 0.96.

Houlihan Lokey (NYSE:HLI) last issued its quarterly earnings data on Wednesday, May 8th. The financial services provider reported $0.86 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.17. Houlihan Lokey had a return on equity of 22.31% and a net margin of 14.67%. The company had revenue of $291.40 million for the quarter, compared to analysts’ expectations of $266.26 million. During the same period in the previous year, the firm posted $0.65 earnings per share. The firm’s revenue for the quarter was up 19.0% on a year-over-year basis. As a group, analysts expect that Houlihan Lokey Inc will post 2.99 EPS for the current year.

Houlihan Lokey Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), financing, financial restructuring, and financial advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial Advisory Services. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as financial sponsors on various transactions.

Further Reading: Market Perform

Institutional Ownership by Quarter for Houlihan Lokey (NYSE:HLI)

Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.